Job Code 260MM
Fate Therapeutics is currently seeking a motivated individual with experience in immunology, cell biology or related field to support our Cancer Immunotherapy group. The successful candidate will be responsible for optimization and execution of engineered lymphoid differentiation protocols, including CAR-T cells, from induced pluripotent stem cells (iPSC) as well as functional assessment of iPSC-derived CAR-T cells in vitro. The successful candidate must have extensive experience with mammalian cell culture. This is a full-time position reporting to a Senior Scientist in Cancer Immunotherapy, and is located at our corporate headquarters in San Diego, CA.
Download a PDF of the job description for more details:
For consideration send cover letter and curriculum vitae to: firstname.lastname@example.org and reference job 260MM.
About Fate Therapeutics, Inc.
Fate Therapeutics is a biopharmaceutical company dedicated to the development of programmed cellular immunotherapeutics for the treatment of cancer and immune disorders. The Company’s cell-based product candidate pipeline is comprised of off-the-shelf immuno-oncology therapeutics, including NK- and T-cell-based candidates derived from induced pluripotent cells, and immuno-regulatory therapeutics, including hematopoietic cell-based candidates for protecting the immune system of patients undergoing hematopoietic cell transplantation and for suppressing auto-reactive T cells of patients with auto-immune disorders. Its adoptive cell therapy candidates are based on the Company’s novel ex vivo cell programming approach, which it applies to modulate the therapeutic function and direct the fate of immune cells.